Benzinga - Thu, 04 Mar 2021 15:02:00 -0400
Benzinga - Thu, 25 Feb 2021 09:08:43 -0400
Benzinga - Wed, 24 Feb 2021 17:19:50 -0400
Benzinga - Wed, 24 Feb 2021 11:03:55 -0400
Benzinga - Wed, 24 Feb 2021 04:35:09 -0400
Benzinga - Tue, 23 Feb 2021 11:29:47 -0400
Benzinga - Sun, 31 Jan 2021 06:22:17 -0400
Benzinga - Wed, 27 Jan 2021 06:26:31 -0400
Benzinga - Wed, 27 Jan 2021 06:10:49 -0400
Benzinga - Tue, 26 Jan 2021 09:07:39 -0400
Benzinga - Tue, 26 Jan 2021 08:05:33 -0400
Benzinga - Tue, 26 Jan 2021 06:15:25 -0400
Benzinga - Mon, 25 Jan 2021 13:46:30 -0400
Benzinga - Mon, 25 Jan 2021 13:14:06 -0400
Benzinga - Mon, 25 Jan 2021 12:29:30 -0400
load more
Sector: Health Care.Industry: Biotechnology
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States followed by China.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-13
REV
Q4 2020Est.ActualSurprise
EPS-0.140-0.050 0.0900
REV40.000K50.030M49.990M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
AUPHAurinia Pharmaceuticals-2.39%1.7B

Aurinia Pharmaceuticals Company Questions & Answers

Q

How do I buy Aurinia Pharmaceuticals (AUPH) stock?

A

You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Aurinia Pharmaceuticals's (AUPH) main competitors?

A

Other companies in Aurinia Pharmaceuticals’s space includes: Precigen (NASDAQ:PGEN), Zentalis Pharmaceuticals (NASDAQ:ZNTL) and ADC Therapeutics (NYSE:ADCT).

Q

What is the target price for Aurinia Pharmaceuticals?

A

The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by SVB Leerink on 2021-01-27. The analyst firm set a price target for 28.00 expecting AUPH to rise to within 12 months (a possible 113.90% upside). 5 analyst firms have reported ratings in the last year.

Q

How much is Aurinia Pharmaceuticals (AUPH) stock ?

A

The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $13.09 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Aurinia Pharmaceuticals (AUPH) dividend?

A

There are no upcoming dividends for Aurinia Pharmaceuticals.

Q

When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?

A
Aurinia Pharmaceuticals’s Q1 earnings are confirmed from now on May 13, 2021.
Q

When is the upcoming split for AUPH?

A

There is no upcoming split for Aurinia Pharmaceuticals.